AUS
NZ
UK
CA
USA
IND
Healthcare
Race Oncology Launches HARNESS-1 Lung Cancer Trial RC220
November 26, 2025 01:27 PM AEDT| By Team Kalkine MediaRace Oncology Ltd (ASX:RAC) receives ethics approval for its HARNESS-1 Phase 1a/b lung cancer trial of RC220 with osimertinib. The multi-centre study will evaluate safety, tolerability, and pharmacokinetics, aiming to provide new insights into NSCLC...
Is Sonic Healthcare Ltd (ASX:SHL) a Key Player for Investors in 2025?
November 25, 2025 05:30 PM AEDT| By Team Kalkine MediaExplore Sonic Healthcare Ltd (ASX:SHL) and its market performance in 2025. Discover revenue trends, financial health, and operational metrics while examining how it positions itself in the broader ASX stock market.
Ramsay’s Hospital Revival Gains Pace Across the ASX 200
November 25, 2025 04:00 PM AEDT| By SamRamsay Health Care’s improved early-year performance signals renewed strength within Australia’s private hospital sector, supported by steadier patient activity, refined capital direction and more balanced operational momentum across major facilities...
Cann Group (ASX:CAN) Announces Quotation of New Securities on ASX
November 24, 2025 01:08 PM AEDT| By SamCann Group (ASX:CAN) announces the quotation of new securities to enhance liquidity, support growth, and strengthen shareholder engagement in the medicinal cannabis sector.
Monash IVF Rebuffs Bid as ASX 200 Spotlight Intensifies
November 24, 2025 11:17 AM AEDT| By SamMonash IVF’s rejection of a takeover proposal has intensified attention across the ASX landscape, highlighting sector strength, company positioning, and broader interest in healthcare operators during shifting market conditions.
SHG Strengthens Industry Presence While All Ordinaries Momentum Expands Around Singular Health Group
November 21, 2025 05:41 PM AEDT| By Team Kalkine MediaSingular Health Group receives renewed attention as digital healthcare modelling, operational discussions, and sector-wide innovation continue shaping its presence within medical technology.
Sonic Healthcare Expands Operational Impact as ASX 100 Momentum Shapes SHL
November 21, 2025 04:11 PM AEDT| By SamSonic Healthcare draws heightened visibility as reported, operational adjustments, and diagnostic service trends continue to shape its presence within the healthcare sector.
Singular Health Group Advances as All Ordinaries Momentum Builds Around SHG
November 21, 2025 03:52 PM AEDT| By SamSingular Health Group continues to attention as its digital healthcare innovations, operational developments, and public commentary shape its presence within the Australian medical technology sector.
CSL Ltd ASX 20 Transformation Moves Into New Phase With Major Global Expansion
November 21, 2025 03:12 PM AEDT| By Team Kalkine MediaCSL advances through a major transformation involving structural refinement, operational alignment and division-specific reorganisation within its global healthcare framework.
Singular Health Group (ASX:SHG) Maintains Strong Cash Runway for Growth
November 21, 2025 12:25 PM AEDT| By Team Kalkine MediaSingular Health Group maintains strong cash reserves, low debt, and strategic growth initiatives, positioning it well within the ASX 200 healthcare sector during periods of market volatility.
MedAdvisor (ASX:MDR) Revenue Struggles Limit ASX 200 Stock Prospects
November 21, 2025 11:48 AM AEDT| By SamMedAdvisor Limited (ASX:MDR) has low revenue growth and a modest P/S ratio. ASX 200 investors monitor performance relative to peers as the company works to improve its market outlook.
CSL Expansion Boosts US Operations: ASX Shares and Market Update
November 21, 2025 11:24 AM AEDT| By SamCSL (ASX:CSL) plans a $1.5 billion US expansion to boost immunoglobulin supply and manufacturing, with a focus on biologics, gene therapies, and operational efficiency amid market volatility.
Sonic Healthcare Faces Fresh Valuation Debate After Market Pullback
November 20, 2025 12:48 PM AEDT| By SamSonic Healthcare’s valuation draws renewed scrutiny as market conditions shift, inviting deeper assessment of its long-term demand, sector fundamentals and evolving strategic context within global healthcare.
Is the Market Misreading NYR as ASX 200 Sentiment Shifts?
November 20, 2025 12:25 PM AEDT| By SamNyrada experiences softer sentiment as ownership dynamics, biotechnology challenges and broader market themes shape perceptions, highlighting the gap between long-term scientific development and short-term market reactions.
Are SHL Shares Being Overlooked as ASX 200 Momentum Builds?
November 20, 2025 12:17 PM AEDT| By SamSonic Healthcare and Xero navigate shifting market sentiment while maintaining strong long-term positions within healthcare and digital finance, underscoring their continued relevance across Australia’s evolving economic landscape.
EMA backs PTX-100 breakthrough as Prescient Therapeutics advances beyond ASX 200
November 19, 2025 12:59 PM AEDT| By SamPrescient Therapeutics advances PTX-100 following orphan designation, strengthening its regulatory direction, clinical progress, and strategic development within targeted oncology, with continued focus on rare lymphoma conditions.
Breakthrough Cancer Screening Advances as BCAL Diagnostics Expands Reach
November 19, 2025 12:55 PM AEDT| By SamAustralia prepares for new blood-based cancer detection tools as BCAL advances clinical integration, expanded screening pathways, and telehealth support to strengthen early diagnostic access nationwide.
COG Financial Services Faces Market Pressure as Ownership Structure Shifts
November 19, 2025 11:59 AM AEDT| By SamCOG Financial Services experiences heightened attention as shifting ownership dynamics prompt fresh analysis. Public, institutional, insider, and private stakeholders collectively shape sentiment and long-term structural direction across the Australi...
All Ordinaries Spotlight on Proteomics International Laboratories and Its Biotech Funding Structure
November 18, 2025 04:27 PM AEDT| By SamExtensive assessment of funding utilisation, scientific operations and expenditure patterns for Proteomics International Laboratories within the All Ordinaries biotechnology sector.
Sonic Healthcare Limited Strengthens Diagnostic Capacity Across ASX 100 Healthcare Activity
November 18, 2025 04:13 PM AEDT| By SamExtensive analysis of Sonic Healthcare Limited’s diagnostic networks, laboratory capabilities, radiology services, scientific structure and wide-reaching role across major Australian healthcare indices.
Advertise your brand on Kalkine Media